These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Mechanisms of extracellularly regulated kinases 1/2 activation in adrenal glomerulosa cells by lysophosphatidic acid and epidermal growth factor. Shah BH; Baukal AJ; Shah FB; Catt KJ Mol Endocrinol; 2005 Oct; 19(10):2535-48. PubMed ID: 15928312 [TBL] [Abstract][Full Text] [Related]
9. Lysophosphatidic acid induces both EGFR-dependent and EGFR-independent effects on DNA synthesis and migration in pancreatic and colorectal carcinoma cells. Tveteraas IH; Aasrum M; Brusevold IJ; Ødegård J; Christoffersen T; Sandnes D Tumour Biol; 2016 Feb; 37(2):2519-26. PubMed ID: 26386720 [TBL] [Abstract][Full Text] [Related]
10. Lysophosphatidic acid inhibits Ca2+ signaling in response to epidermal growth factor receptor stimulation in human astrocytoma cells by a mechanism involving phospholipase C(gamma) and a G(alphai) protein. Hernández M; Barrero MJ; Crespo MS; Nieto ML J Neurochem; 2000 Oct; 75(4):1575-82. PubMed ID: 10987838 [TBL] [Abstract][Full Text] [Related]
11. Lysophosphatidic acid-regulated mitogenic ERK signaling in androgen-insensitive prostate cancer PC-3 cells. Kue PF; Taub JS; Harrington LB; Polakiewicz RD; Ullrich A; Daaka Y Int J Cancer; 2002 Dec; 102(6):572-9. PubMed ID: 12447997 [TBL] [Abstract][Full Text] [Related]